Assessing the economic burden of breast cancer in a US managed care population

Breast Cancer Research and Treatment

Volumn 109, Issue 2, 2008, Pages 367-377

  Barron, John J ^a   Quimbo, Ralph ^a   Nikam, Prashant T ^b   Amonkar, Mayur M ^b  

^a HEALTHCORE INC   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Administrative claims; Breast cancer; Healthcare costs; Healthcare utilization; Prevalence

Indexed keywords

ANASTROZOLE; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; FULVESTRANT; GEMCITABINE; GOSERELIN; LETROZOLE; MEGESTROL; METHOTREXATE; NAVELBINE; PACLITAXEL; TAMOXIFEN; TOREMIFENE; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DRUG COST; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MANAGED CARE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMORBIDITY; COST OF ILLNESS; FEMALE; HEALTH RESOURCES; HUMANS; INFUSIONS, INTRAVENOUS; MANAGED CARE PROGRAMS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 43149114465     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9650-4     Document Type: Article

References (38)

1. Brown ML, Lipscomb J, Snyder C (2001) The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 22:91-113
2. Osteen R. Breast Cancer (2001) In: Lenhard R, Osteen R, Gansler T (eds) Clinical oncology. American Cancer Society
3. American Cancer Society (2006) Cancer Statistics 2006: a presentation from the American Cancer Society. http://www.cancer.org/downloads/STT/ Cancer_Statistics_2006_Presentation.ppt#256,1,Cancer Statistics 2006
4. Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
5. Ries L, Eisner M, Kosary C et al (2005) SEER Cancer Statistics Review, 1975-2002. http://seer.cancer.gov/csr/1975_2002/ National Cancer Institute
6. Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168-183
7. Elkin EB, Hudis C, Begg CB et al (2005) The effect of changes in tumor size on breast carcinoma survival in the US: 1975-1999. Cancer 104:1149-1157
8. National Comprehensive Cancer Network (2006) NCCN Practical Guidelines in Oncology: Breast Cancer, v.2.2006
9. Bloom BS, de Pouvourville N, Chhatre S et al (2004) Breast cancer treatment in clinical practice compared to best evidence and practice guidelines. Br J Cancer 90:26-30
10. Lazovich DA, White E, Thomas DB et al (1991) Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433-3438
11. Malin JL, Schuster MA, Kahn KA et al (2002) Quality of breast cancer care: what do we know? J Clin Oncol 20:4381-4393
12. Fireman BH, Quesenberry CP, Somkin CP et al (1997) Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 18:51-76
13. Legorreta AP, Brooks RJ, Leibowitz AN et al (1996) Cost of breast cancer treatment. A 4-year longitudinal study. Arch Intern Med 156:2197-2201
14. Taplin SH, Barlow W, Urban N et al (1995) Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 87:417-426
15. Rao S, Kubisiak J, Gilden D (2004) Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat 83:25-32
16. American Cancer Society (2005) Breast Cancer Facts & Figures 2005-2006. http://www.cancer.org/downloads/STT/CAFF2005BrFacspdf2005.pdf
17. Kutikova L, Bowman L, Chang S et al (2005) The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 50:143-154
18. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
19. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619
20. Nuttall M, van der MJ, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59:265-273
21. Farley JF, Harley CR, Devine JW (2006) A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care 12:110-119
22. Bernardini J, Callen S, Fried L et al (2004) Inter-rater reliability and annual rescoring of the Charlson comorbidity index. Adv Perit Dial 20:125-127
23. O'Connor GT, Plume SK, Olmstead EM et al (1991) A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. JAMA 266:803-809
24. Roos LL, Sharp SM, Cohen MM et al (1989) Risk adjustment in claims-based research: the search for efficient approaches. J Clin Epidemiol 42:1193-1206
25. Roos LL, Sharp SM, Cohen MM (1991) Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol 44:881-888
26. SEER 2003. SEER Surveillance Epidemiology and End Results. http://seer.cancer.gov/statfacts/html/breast.html. National Cancer Institute
27. Ballard-Barbash R, Potosky AL, Harlan LC et al (1996) Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726
28. Janjan N, Nattinger A, Young M et al (1993) First-year treatment charges for early-stage vs locally advanced breast cancer. Breast Dis 6:23-27
29. Baker MS, Kessler LG, Urban N et al (1991) Estimating the treatment costs of breast and lung cancer. Med Care 29:40-49
30. Warren J, Brown M, Fay M et al (2002) Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 20:307-331
31. Riley GF, Potosky AL, Lubitz JD et al (1995) Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 33:828-841
32. Hewitt M, Simone J (1999) Ensuring quality cancer care. National Academy Press
33. Silliman RA, Troyan SL, Guadagnoli E et al (1997) The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer 80:1326-1334
34. Brown ML, Riley GF, Schussler N et al (2002) Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40:4-17
35. Munoz E, Shamash F, Friedman M et al (1986) Lumpectomy vs mastectomy. The costs of breast preservation for cancer. Arch Surg 121:1297-1301
36. Barlow WE, Taplin SH, Yoshida CK et al (2001) Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst 93:447-455
37. Desch CE, Penberthy LT, Hillner BE et al (1999) A sociodemographic and economic comparison of breast reconstruction, mastectomy, and conservative surgery. Surgery 125:441-447
38. Potosky AL, Merrill RM, Riley GF et al (1997) Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 89:1683-1691